ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

National Cancer Institute (NCI) · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
disorderslymphomamonoclonal-antibody
epstein-barr virus infections, lymphoma, lymphoproliferative disorder, disorders, lymphoproliferative, monoclonal antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 844338
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.